A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (The SKYLIGHT Trial)
A legfontosabb adatok
- Hol
- Atlanta, Baton Rouge, Birmingham, Boston, Bowling Green, Coral Gables, Detroit, Durham, Indianapolis, Irvine, Las Vegas, Mill Creek, Mt. Pleasant, Murray, Nashville, New York, Oklahoma City, Owensboro, Prosper, Rogers, Smyrna, The Bronx és Tyler (Egyesült Államok)Mind a 26 helyszín megnézése
- Fázis
- 2. fázis
Neked szólhat?
Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.
- 18 és 75 év között vagy?
Forrás: NCT07766005: ki vehet részt
Helyszínek itt: Egyesült Államok
- Atlanta, GeorgiaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Baton Rouge, LouisianaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Birmingham, AlabamaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Boston, MassachusettsHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Boston, MassachusettsHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Bowling Green, KentuckyHospital not named in the registryContact: SKYLIGHT Trial CenterRésztvevőt keres
- Coral Gables, FloridaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Detroit, MichiganHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Durham, North CarolinaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Indianapolis, IndianaHospital not named in the registryContact: SKYLIGHT Trial CenterRésztvevőt keres
- Irvine, CaliforniaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Las Vegas, NevadaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Las Vegas, NevadaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Mill Creek, WashingtonHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Mt. Pleasant, South CarolinaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Murray, UtahHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Nashville, TennesseeHospital not named in the registryContact: SKYLIGHT Trial CenterRésztvevőt keres
- New YorkHospital not named in the registryContact: SKYLIGHT Trial CenterRésztvevőt keres
- Oklahoma City, OklahomaHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Owensboro, KentuckyHospital not named in the registryContact: SKYLIGHT Trial CenterRésztvevőt keres
- Prosper, TexasHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Rogers, ArkansasHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Smyrna, TennesseeHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- The Bronx, New YorkHospital not named in the registryContact: SKYLIGHT Trial CenterRésztvevőt keres
- Tyler, TexasHospital not named in the registryContact: SKYLIGHT Trial CenterToborzás még nem indult
- Tyler, TexasHospital not named in the registryContact: SKYLIGHT Trial CenterRésztvevőt keres
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- Spyre Therapeutics, Inc.
- Azonosító
- NCT07766005
- A regiszteradat frissítve
- 2026. október 19.
- Eredeti leírás
This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease receiving advanced standard of care treatment. About 150 participants will be assigned by chance to receive either SPY072 or placebo for 16 weeks. Participants will be followed after the treatment period to evaluate safety and how long treatment effects may last.A teljes eredeti leírásKevesebb
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-concept Trial to Assess the Efficacy and Safety of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa Receiving Standard of Care Treatment
This Phase 2 study will test whether the investigational medicine, SPY072, improves hidradenitis suppurativa (HS) in adults with moderate to severe disease receiving advanced standard of care treatment. About 150 participants will be assigned by chance to receive either SPY072 or placebo for 16 weeks. Participants will be followed after the treatment period to evaluate safety and how long treatment effects may last.
Bevonási feltételek: Clinical diagnosis of Hidradenitis Suppurativa with symptoms for at least 6 months before screening; Hidradenitis suppurativa lesions in at least 2 distinct anatomical areas, with at least 1 area meeting Hurley Stage II or III criteria at screening and Day 1; Total abscess and/or inflammatory nodule count of at least 5 at screening and Day 1; Documented inadequate response, intolerance, or contraindication to at least 1 systemic therapy for hidradenitis suppurativa.
Kizáró feltételek: Hidradenitis suppurativa lesion expected to require incision and drainage within 4 weeks before Day 1, or major hidradenitis suppurativa surgery within 12 weeks before Day 1; Another inflammatory or skin condition that could interfere with assessment of hidradenitis suppurativa; More than 20 draining tunnels at screening or Day 1.